Your browser doesn't support javascript.
loading
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups.
Quinn, D I; Ng, C F; Grande, E; Kwon, T G; Linke, R; Lee, J-L; Rosbrook, B; Thakur, M N; Eto, M; Gross-Goupil, M.
Afiliação
  • Quinn DI; Division of Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, USA. Electronic address: diquinn@med.usc.edu.
  • Ng CF; Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
  • Grande E; Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
  • Kwon TG; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Linke R; SFJ Pharmaceuticals, Pleasanton, USA.
  • Lee JL; Department of Medical Oncology, University of Ulsan College of Medicine, Asian Medical Center, Seoul, Republic of Korea.
  • Rosbrook B; Pfizer Oncology, New York, USA.
  • Thakur MN; Pfizer, Sandwich, UK.
  • Eto M; Department of Urology, Kyushu University, Fukuoka, Japan.
  • Gross-Goupil M; Department of Medical Oncology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
ESMO Open ; 6(3): 100105, 2021 06.
Article em En | MEDLINE | ID: mdl-33901868
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article